silicon

Silicon is a trace mineral that is the second most abundant element in the Earth's crust after oxygen, and it is present in soil, plants, and in small amounts in the human body. Although silicon is found in many tissues, including connective tissues such as bone, skin, and blood vessels, it is not officially categorized as an essential nutrient for humans because there is insufficient evidence demonstrating that its absence causes a distinct deficiency syndrome comparable to classic nutrient deficiencies. However, silicon participates in physiological processes that support connective tissue integrity, particularly through interactions with collagen and glycosaminoglycans necessary for bone and cartilage health. Silicon is found in foods in various forms, including orthosilicic acid and silicon dioxide. Orthosilicic acid (OSA) is considered the most bioavailable form, while polymerized silica forms in plants are less readily absorbed. Historically, interest in silicon's biological roles emerged from animal studies showing that diets extremely low in silicon resulted in bone abnormalities, underscoring its potential importance in bone and connective tissue formation. Although the Institute of Medicine did not establish a Recommended Dietary Allowance (RDA) for silicon due to lack of conclusive data, many researchers propose suggested intake ranges for nutritional support based on observational studies and average dietary intakes in populations. In typical Western diets, adult silicon intake ranges between approximately 20 and 50 mg per day, mainly from plant-based foods such as whole grains, cereals, vegetables, and certain beverages. Because silicon is abundant in plant foods and water, most people consuming unprocessed plant-rich diets obtain adequate amounts without supplementation. The mechanisms by which silicon may influence physiological outcomes include promoting collagen synthesis, influencing bone mineralization by supporting hydroxyapatite formation, and contributing to connective tissue structural integrity. Dietary silicon moves through the body largely as orthosilicic acid and is excreted in urine, with a significant portion of consumed silicon detectable in urinary excretion, indicating absorption and systemic distribution.

Silicon’s primary recognized roles in humans revolve around connective tissue health, particularly bone metabolism and the synthesis of collagen and glycosaminoglycans. Biologically, silicon is believed to contribute to the formation of hydroxyapatite crystals, an essential component of bone matrix, through interactions that facilitate mineral deposition. Epidemiological studies have identified positive associations between dietary silicon intake and bone mineral density in adult men and women, with higher intakes correlating with greater bone density at hip sites. Such observations lend support to a role for silicon in bone health that complements the actions of calcium and vitamin D. Silicon may also influence collagen synthesis, which is critical for the structure of skin, cartilage, and blood vessels. In vitro experiments demonstrate that orthosilicic acid can stimulate type I collagen synthesis and osteoblastic differentiation, mechanisms by which silicon might support skeletal and connective tissue integrity. Observational data also suggest that intakes of silicon at moderate dietary levels are associated with markers of bone formation and inhibit markers of bone resorption, although definitive intervention trials in humans remain limited and mixed. Beyond skeletal support, silicon is often associated with the maintenance of healthy skin, hair, and nails, though human clinical evidence remains limited. Its purported benefits in this domain are thought to arise from silicon’s involvement in connective tissue properties. Silicon has also been investigated for potential roles in cardiovascular and neurodegenerative contexts, where preliminary data hint at possible protective effects, perhaps through interactions with other minerals and cellular binding roles, although these areas require more robust clinical evidence. Ongoing research continues to clarify silicon’s broader physiological contributions and the mechanisms by which it may influence human health.

Despite the mounting interest in silicon’s physiological roles, authoritative bodies such as the National Institutes of Health Office of Dietary Supplements and the Institute of Medicine have not set a formal Recommended Dietary Allowance (RDA) for silicon due to insufficient evidence demonstrating essentiality. Consequently, there are no official intake recommendations broken down by age and sex as exist for other nutrients. Observational studies and dietary surveys indicate that habitual intakes in Western populations typically range from approximately 20 to 50 mg per day, with individuals consuming plant-rich diets tending toward the higher end of this range. Some researchers propose that an intake near 25 mg per day might be reasonable to support bone and connective tissue health based on epidemiological data correlating higher intakes with favorable bone density outcomes. However, these suggestions are not formal recommendations and should be interpreted in the context of overall dietary patterns. Due to the absence of a defined RDA, clinicians and nutrition scientists often consider dietary patterns that naturally include silicon-rich foods—such as whole grains, cereals, vegetables, and beverages like mineral water and beer—as a pragmatic approach to achieving adequate silicon exposure. Additionally, factors such as age, sex hormone status (e.g., postmenopausal women), and dietary composition influence silicon intake and its potential impact on health outcomes. More research is needed to determine whether specific intake targets should be established, and to clarify the potential interactions with other nutrients such as calcium, magnesium, and vitamin D. Until such evidence emerges, a balanced diet emphasizing diverse plant foods remains the preferred strategy for supporting silicon intake.

Because silicon is not officially classified as an essential nutrient, classic deficiency syndromes with well-defined clinical features comparable to scurvy or rickets have not been established in humans. Nevertheless, animal studies and limited human observations suggest that suboptimal intakes may be associated with conditions related to compromised connective tissue integrity. In animal models fed silicon-deprived diets, researchers have observed skeletal abnormalities, including poorly formed joints, decreased cartilage content, and altered bone structure, indicating that extremely low silicon exposures can disrupt normal bone and connective tissue development. In humans, the absence of well-defined deficiency symptoms makes clinical diagnosis challenging. However, some observational data associate lower silicon intakes with reduced bone mineral density and markers of bone turnover indicative of increased resorption. Other nonspecific symptoms that have been proposed in the context of low silicon exposure include features such as brittle nails, thinning hair, and diminished skin elasticity, although robust clinical evidence quantifying these associations is lacking. Populations at potentially higher risk for suboptimal silicon status include individuals consuming highly processed diets with limited whole grains, cereals, and vegetables—key dietary sources of silicon. Additionally, older adults with lower dietary diversity or those with gastrointestinal conditions affecting nutrient absorption might exhibit lower silicon bioavailability. Serum and urinary silicon concentrations have been used in research settings to estimate silicon status, with fasting serum ranges reported in some studies, but these biomarkers are not routinely used clinically. As serum silicon levels reflect recent intake and absorption, consistently low values might indicate inadequate intake, but standardized reference ranges and diagnostic criteria remain undefined. Clinicians should interpret any measurements of silicon status cautiously, within the broader context of the individual’s diet and health status.

Silicon occurs widely in plant-based foods, particularly in unrefined grains and cereals, vegetables, and certain beverages. Whole grains and cereals rank among the richest dietary sources of silicon due to the high concentrations of silica in their outer husks and bran components. For example, barley and brown rice contain substantial silicon levels per 100 g amount, making them valuable contributors in diets seeking to support connective tissue health. Other notable plant foods include buckwheat, strawberries, lentils, broccoli, bananas, avocados, hazelnuts, and cucumbers, offering silicon in varying amounts that cumulatively support typical intakes. Green beans, in particular, have been highlighted as a well-absorbed source of silicon, while beverages such as beer and mineral water supply orthosilicic acid, a highly bioavailable form of silicon. Importantly, the form of silicon present in food influences its bioavailability; orthosilicic acid found in water and certain beverages is absorbed more readily than polymerized forms found in some plant matrices. Although animal products generally contain lower silicon levels than plant foods, they contribute modest amounts in mixed diets. The consumption of whole, minimally processed foods maximizes silicon intake, as food processing can substantially reduce silicon content. Incorporating a mix of whole grains, legumes, vegetables, fruits, nuts, and beverages such as mineral water can help achieve dietary silicon exposures commonly observed in healthy populations with typical intakes of 20–50 mg per day.

Once consumed, dietary silicon is absorbed in the gastrointestinal tract primarily in the form of orthosilicic acid, a soluble monomeric form that circulates systemically and can contribute to tissue deposition and excretion. The bioavailability of silicon varies considerably depending on the chemical form and the food matrix. Orthosilicic acid and its stabilized supplements exhibit higher absorption rates than polymerized silica compounds found in some plant sources. Comparative studies measuring urinary silicon excretion—a surrogate indicator of absorption—demonstrate that orthosilicic acid solutions and alcohol-free beer yield relatively high absorption percentages, whereas polymerized forms such as those in bananas exhibit lower uptake. Factors such as co-ingestion with other dietary components, food processing, and gastrointestinal transit affect silicon dissolution and uptake. Additionally, mineral water with high silica content can be a significant source of bioavailable silicon. Absorption efficiency appears to range broadly, with urinary excretion studies indicating that a substantial portion of ingested silicon is absorbed and excreted, underscoring the relevance of the form in which silicon is consumed.

Given the lack of an official RDA and the variability in dietary silicon intakes, some individuals consider supplementation to achieve targeted exposures. Silicon supplements commonly contain stabilized orthosilicic acid, choline-stabilized orthosilicic acid, or other organic silicon compounds designed to enhance bioavailability. Research evaluating the efficacy of silicon supplementation on clinical outcomes such as bone mineral density and connective tissue properties remains limited and mixed. Some human studies suggest that supplemental silicon in combination with calcium and vitamin D may positively influence bone turnover markers and femoral bone mineral density in specific populations such as postmenopausal women, while other research underscores the need for clearer efficacy thresholds. Because typical diets supply silicon in amounts sufficient for most individuals consuming a variety of plant foods, routine supplementation is generally not necessary for the average healthy adult. However, individuals with low dietary silicon due to restrictive diets or malabsorption may benefit from supplementation under healthcare guidance. Supplements should be selected with attention to the form of silicon, bioavailability data, and product quality, and used in conjunction with other nutrients essential for bone and connective tissue health.

Silicon’s safety profile appears favorable, with no officially established tolerable upper intake level due to limited evidence of adverse effects at typical dietary exposures. Regulatory assessments have indicated that total dietary silicon intakes between 20 and 50 mg per day are generally considered harmless, and supplemental intakes up to 700 mg per day have been evaluated as posing no significant safety concern in adults when derived from specific forms such as silicon dioxide. Adverse effects from dietary silicon are rare, and most safety concerns arise from inhalation of crystalline silica in occupational settings, which is associated with lung diseases such as silicosis, rather than from oral intake. Nonetheless, extremely high supplemental doses should be approached cautiously, particularly in the context of unknown long-term effects and potential interactions with the absorption of other minerals. Healthcare providers should evaluate individual risk factors before recommending high-dose silicon supplementation.

Silicon does not have widely documented interactions with pharmaceuticals, and current evidence does not indicate major drug interference through typical dietary or supplemental intakes. However, because silicon can form complexes with certain minerals and may influence mineral metabolism, theoretical interactions with medications affecting mineral status, such as bisphosphonates for osteoporosis or chelating agents, warrant consideration. Clinicians should evaluate individual medication profiles when patients are considering silicon supplementation, particularly at higher doses, to monitor potential effects on overall mineral balance.

Common Forms: orthosilicic acid, choline-stabilized orthosilicic acid, monomethylsilanetriol

Typical Doses: 20–50 mg/day in studies; up to 700 mg/day appears safe in adults

When to Take: With meals

Best Form: orthosilicic acid

⚠️ Interactions: potential interactions with mineral metabolism affecting calcium